TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 49 filers reported holding TALARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,714 | -30.9% | 36,197 | -25.2% | 0.00% | – |
| Q2 2023 | $147,120 | -71.5% | 48,395 | -82.4% | 0.00% | – |
| Q1 2023 | $516,314 | +3695.9% | 274,635 | +1959.4% | 0.00% | – |
| Q4 2022 | $13,602 | -73.3% | 13,336 | -30.5% | 0.00% | – |
| Q3 2022 | $51,000 | -50.5% | 19,189 | -15.5% | 0.00% | – |
| Q2 2022 | $103,000 | -69.4% | 22,697 | -33.7% | 0.00% | – |
| Q1 2022 | $337,000 | -34.1% | 34,218 | +2.2% | 0.00% | – |
| Q4 2021 | $511,000 | +58.2% | 33,473 | +40.4% | 0.00% | – |
| Q3 2021 | $323,000 | +20.1% | 23,845 | +30.6% | 0.00% | – |
| Q2 2021 | $269,000 | – | 18,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |